Personalized prediction for a 82 year old man who takes Digoxin Pediatric (an AI-powered real world drug study)

Summary:

This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.

What are the drugs?

Digoxin pediatric has active ingredients of digoxin. eHealthMe is studying from 20 Digoxin pediatric users. Check the latest studies of Digoxin pediatric.

What are the conditions?

Atrial fibrillation (fibrillation of the muscles of the atria of the heart) is found to be associated with 2,921 drugs and 3,815 conditions by eHealthMe. Check the latest studies of Atrial fibrillation.

What are the symtoms?

Atrial fibrillation (fibrillation of the muscles of the atria of the heart) is found to be associated with 2,921 drugs and 3,815 conditions by eHealthMe. Check the latest studies of Atrial fibrillation.

Potential side effects:

Anaemia

5.58% for males aged 82 (±5) who have atrial fibrillation

Atrial fibrillation/flutter

100.0% for males aged 82 (±5) who take digoxin pediatric and have atrial fibrillation
100.0% for males aged 82 (±5) who have atrial fibrillation with atrial fibrillation

Death

8.84% for males aged 82 (±5) who take digoxin pediatric

Gastrointestinal haemorrhage

12.35% for males aged 82 (±5) who have atrial fibrillation

Potential co-existing conditions:

Cardiac failure

6.93% for males aged 82 (±5) who have atrial fibrillation with atrial fibrillation

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

Related publications that referenced our studies

Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.